title: Catastrophic tumour lysis syndrome following single dose of imatinib.
authors.forename: Colm
authors.initials: C
authors.lastname: Keane
authors.forename: Andrea
authors.initials: A
authors.lastname: Henden
authors.forename: Robert
authors.initials: R
authors.lastname: Bird
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D015275:Tumor Lysis Syndrome / Q000097:blood* / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate